Manufacturer's investigation conclusion: a direct correlation between the centrimag blood pump and the reported aortic dissection and patient outcome could not be determined through this evaluation.The account reported two possible lot numbers for the centrimag blood pump and could not determine which one was correct.Review of the device history record (dhr) for the centrimag blood pump, lot number l06968-la1 revealed no deviations from manufacturing or quality assurance specifications.Review of the dhr for the centrimag blood pump, lot number l06969-la8 revealed no deviations from manufacturing or quality assurance specifications.The outside of united states (ous) centrimag blood pump instructions for use (ifu) list warnings and cautions regarding the use of the centrimag circulatory support system: ifu warning #9: possible side effects include, but are not limited to: infection, mechanical failure, hemolysis, end organ dysfunction, neurologic dysfunction, bleeding, and embolic phenomena.These are potential side effects with all mechanical circulatory support systems ifu warning #15: it is intended that systemic anticoagulation be utilized while this device is in use.Anticoagulation levels should be determined by the physician based on risks and benefits to the patient.Ifu warning #16: potential risk to the patient should be evaluated prior to changing a centrimag vad.Ifu warning #17: frequent patient and device monitoring is recommended.Ifu caution #2: this device should only be used by persons thoroughly trained in extracorporeal circulation procedures.Ifu caution #14: always have a spare centrimag vad, centrimag back-up console and spare equipment readily available for change.No further information was provided.The manufacturer is closing the file on this event.
|